Literature DB >> 9990357

Vitiligo melanocytes in long-term culture show normal constitutive and cytokine-induced expression of intercellular adhesion molecule-1 and major histocompatibility complex class I and class II molecules.

S J Hedley1, R Metcalfe, D J Gawkrodger, A P Weetman, S Mac Neil.   

Abstract

The aetiology of vitiligo remains unclear. An autoimmune involvement has been suggested and, in this study, we examine whether melanocytes cultured from unaffected regions of the skin of vitiligo patients are more susceptible to immune attack by investigating constitutive and cytokine-stimulated expression of intercellular adhesion molecule-1 (ICAM-1) (under three media variants) and major histocompatibility complex (MHC) class I and class II (under one medium). Both normal and vitiligo melanocytes had similarly low constitutive expression of ICAM-1 and MHC class II molecules, whereas > 95% of cells had high constitutive expression of MHC class I. Normal and vitiligo melanocytes showed similar and significant increases in the expression of all three immune-related molecules in response to the cytokine, interferon-gamma. The expression of ICAM-1 was also similarly increased by the cytokine, tumour necrosis factor-alpha in both cells. Additionally, it was noted that, once the melanocyte cultures were established under experimental conditions, the rate of proliferation of vitiligo melanocytes did not differ significantly from that of normal melanocytes. In conclusion, we suggest that vitiligo melanocytes, once in culture, do not have intrinsic differences from normal melanocytes with respect to the expression of immune-related molecules.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9990357     DOI: 10.1046/j.1365-2133.1998.02550.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1.

Authors:  Matthew P Rausch; Kari R Irvine; Paul A Antony; Nicholas P Restifo; Peter Cresswell; K Taraszka Hastings
Journal:  J Immunol       Date:  2010-07-28       Impact factor: 5.422

2.  Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo.

Authors:  Mitesh Dwivedi; Naresh C Laddha; Kriti Shah; Bela J Shah; Rasheedunnisa Begum
Journal:  J Interferon Cytokine Res       Date:  2013-06-18       Impact factor: 2.607

Review 3.  Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo.

Authors:  K C Webb; R Tung; L S Winterfield; A B Gottlieb; J M Eby; S W Henning; I C Le Poole
Journal:  Br J Dermatol       Date:  2015-08-25       Impact factor: 9.302

4.  Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility.

Authors:  Naresh C Laddha; Mitesh Dwivedi; Amina R Gani; Mohmmad Shoab Mansuri; Rasheedunnisa Begum
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

Review 5.  Melanogenesis Connection with Innate Immunity and Toll-Like Receptors.

Authors:  Saaya Koike; Kenshi Yamasaki
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

6.  Hair Graying Regulators Beyond Hair Follicle.

Authors:  Jing Chen; Yixin Zheng; Chen Hu; Xuexiao Jin; Xiaoping Chen; Ying Xiao; Chaochen Wang
Journal:  Front Physiol       Date:  2022-02-24       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.